MDGL Madrigal Pharmaceuticals, Inc. Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
00:07
Jul 27
seedy19tron Biotech trader, L/S
Buy MDGL as a second-tier derisked/M&A candidate within the speaker's biotech conviction list; lower conviction than top-tier names but still recommended for capital deployment.
MDGL 1ST
MED
14:28
May 17
seedy19tron Biotech trader, L/S
Buy these biotech names after derisking events (post-data capital raises); upcoming CD data catalyst could double market capitalization in 5-6 months.
MDGL
HIGH

About MDGL Analyst Coverage

Buzzberg tracks MDGL (Madrigal Pharmaceuticals, Inc.) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (50%). 2 total trade ideas tracked. Past 7 days: 1 bullish. Latest voices: seedy19tron.